The optimal professional group to review this material would be a Panel of Senior Epidemiologists and Neuro-pathology Specialists, as the text centers on a potential disease cluster, diagnostic criteria, public health response, and the differential diagnosis of complex neurological symptoms.
Abstract
This report details the protracted controversy surrounding the "New Brunswick Neurological Syndrome of Unknown Cause," a proposed illness based on observations by neurologist Dr. Alier Marrero. Beginning in 2019, Marrero documented an expanding cluster (eventually reaching 500 patients) of individuals exhibiting a highly heterogeneous and rapidly progressing constellation of neurological and psychiatric symptoms, initially resembling Creutzfeldt-Jakob Disease (CJD). Early collaboration with federal scientists was halted by the New Brunswick provincial government, fueling patient advocacy claims of an industrial environmental poisoning cover-up (specifically citing glyphosate).
The mainstream scientific consensus, formalized in a 2025 publication in the Journal of the American Medical Association (JAMA), concluded that the purported syndrome did not exist. Instead, the patients suffered from known conditions, including Functional Neurological Disorder (FND), various dementias, and other medical issues. The study attributed the cluster phenomenon to serial misdiagnosis by Dr. Marrero. The controversy highlights systemic issues in public health communication, the complexity of nosological assignment for FND, and severe consequences for patients, including the documented use of Medical Assistance in Dying (MAID) due to lack of a definitive non-mystery diagnosis.
Summary of Transcript
Initial Observations (Early 2019): Dr. Alier Marrero, a New Brunswick neurologist, reported an increasing number of patients (initially over 20, later ballooning to 500) presenting with unexplained, rapidly progressing CJD-like symptoms, though all were negative for CJD.
Symptom Variability: Marrero’s notes documented an unusually broad and inconsistent range of symptoms, including profound dementia, unsteadiness, jerking movements, Capgras Delusion (belief a loved one is an imposter), waking hallucinations, and physical symptoms like muscle atrophy, limb pain, and excessive sweating/drooling.
Federal Engagement and Funding: A multi-disciplinary working group was formed, and the condition was temporarily named the "New Brunswick Neurological Syndrome of Unknown Cause." The Canadian Institutes of Health Research (CIHR) offered C$5 million for investigation, reflecting the seriousness of the initial scientific interest.
Internal Scientific Dissent: Neuropathologist Dr. Gerard Jansen, attached to the CJD Surveillance System, strongly disputed the existence of a mystery syndrome, characterizing the clinical documentation as a "diarrhea of symptoms." Jansen’s autopsies of deceased cluster patients revealed known conditions (Alzheimer's, Lewy body dementia).
Environmental Toxin Hypothesis: Marrero and patient advocates promoted the theory of industrial environmental poisoning, specifically focusing on chronic glyphosate exposure (used extensively by the forestry industry) and heavy metals. Marrero claimed "beyond 100" patients showed elevated levels of these substances.
Provincial Disengagement (May 2021): The New Brunswick government suspended its collaboration with federal scientists and declined the C$5 million funding offer. Provincial officials expressed concern that Marrero and the working group were circumventing standard protocols, leading advocates to suspect a government-orchestrated cover-up intended to avoid scrutiny of industrial environmental practices.
Marrero's Dismissal (August 2022): Marrero was terminated from the Mind Clinic (set up to treat the cluster) due to "deficiencies in [his] performance." Of 105 active cluster patients, 94 chose to follow Marrero outside the clinic, demonstrating intense patient loyalty.
Confirmed Alternative Diagnoses: Patients who sought second opinions (the 11 who remained at the clinic) received definitive diagnoses. Examples include frontotemporal dementia (FTD) and Functional Neurological Disorder (FND).
JAMA Study Debunking (May 2025): A research paper led by Dr. Anthony Lang, published in JAMA, analyzed 25 cluster patients (live and autopsy) and found that all suffered from known, pre-existing conditions. The authors concluded the probability of a new disease was nearly 100% false and attributed the cluster to "serial misdiagnosis."
Ethical and Patient Consequences: The report highlights that the lack of a concrete diagnosis under the cluster designation has led multiple patients, including Jillian Lucas, to pursue Medical Assistance in Dying (MAID), which Marrero supported despite the absence of a terminal diagnosis.
Lack of Physician Sanction: Despite serious allegations of misdiagnosis and procedural issues, Marrero remains uninvestigated by regulatory bodies, primarily because his patients have maintained strong loyalty and have not filed formal complaints.